BCL2 and neoplasm: We have validated these markers together with BCL2 in a panel of 51 bladder tumors representing various tumor stages (22 low grade Ta tumors, 2 high grade Ta tumors, 8 T1 tumors, 17≥T2 tumors, and 2 Tis).